Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA
With
Hospital Clínico Universitario de Valladolid
Age
18–99
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with primary open angle glaucoma or ocular hypertension as defined in Early Manifest Glaucoma Trial
\> 18 years old
Signed informed consent
3 or more months under monotherapy treatment with tafluprost 0.0015%, latanoprost 0.005% with BAK 0.2mg/ml or latanoprost 0.005%.
Untreated patients with ocular hypertension must be treatment naïve for the pathology.
No presence or history of previous ocular diseases other than glaucoma or ocular hypertension, started before the use of hypotensive medication.
Any topical treatment other than the evaluated in this study in the last 3 months.
In case of artificial teardrops use, only non conservative ones are allowed, with no more than 4 times per day use, and treatment must be suspended 5 days before inclusion.
Use of contact lenses in the las 4 weeks.
Any mental or physical disease that may prevent performing the required tests for the study.
You may not be if
Ocular surgery in the previous 6 months.
Clareo Health | Inflammatory Biomarkers in Ocular Surface in Primary Open Angle Glaucoma or Ocular Hypertension Under Topical Prostaglandins
